Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
InSightec Ltd Company Overview 4
InSightec Ltd Company Snapshot 4
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
InSightec Ltd – Pipeline Analysis Overview 7
InSightec Ltd – Key Facts 7
InSightec Ltd – Major Products and Services 8
InSightec Ltd Pipeline Products by Development Stage 9
InSightec Ltd Ongoing Clinical Trials by Trial Status 11
InSightec Ltd Pipeline Products Overview 13
ExAblate – Brain Cancer 13
ExAblate – Brain Cancer Product Overview 13
ExAblate – Brain Cancer Clinical Trial 14
ExAblate – Breast Cancer 15
ExAblate – Breast Cancer Product Overview 15
ExAblate – Breast Cancer Clinical Trial 16
ExAblate – Liver Cancer 17
ExAblate – Liver Cancer Product Overview 17
ExAblate 2100 Prostate System 18
ExAblate 2100 Prostate System Product Overview 18
ExAblate 2100 Prostate System Clinical Trial 19
ExAblate Neuro 20
ExAblate Neuro Product Overview 20
ExAblate Neuro Clinical Trial 21
InSightec Ltd – Key Competitors 22
InSightec Ltd – Key Employees 23
InSightec Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
InSightec Ltd, Recent Developments 25
Nov 29, 2017: The Taiwanese Food and Drug Administration Approved Exablate Neuro for the Treatment of Essential Tremor 25
Oct 27, 2017: Insightec’s Exablate Neuro Named Best Medical Technology At Esteemed Prix Galien Awards 2017 25
Oct 25, 2017: INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson’s Disease 26
Aug 23, 2017: The First MR-Guided Focused Ultrasound Treatment for Essential Tremor Was Performed in Taiwan 26
Aug 16, 2017: INSIGHTEC Announces Expanded Reach of MR-Guided Focused Ultrasound 26
May 17, 2017: Sperling Medical Successfully Treats First Florida Tremor Cases 27
May 09, 2017: INSIGHTEC Receives FDA Approval for Exablate Neuro for 1.5T MRI in the Treatment of Essential Tremor 28
May 02, 2017: Sperling Prostate Center Joins MR-Guided Focused Ultrasound Clinical Study 28
Apr 20, 2017: Insightec: First Patient With Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Children’s Hospital 28
Dec 20, 2016: The Japanese Ministry of Health, Labor and Welfare Approved Exablate Neuro System For The Treatment of Essential Tremor 29
Appendix 30
Methodology 30
About GlobalData 32
Contact Us 32
Disclaimer 33
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
InSightec Ltd Pipeline Products by Equipment Type 5
InSightec Ltd Pipeline Products by Indication 6
InSightec Ltd Ongoing Clinical Trials by Trial Status 6
InSightec Ltd, Key Facts 7
InSightec Ltd, Major Products and Services 8
InSightec Ltd Number of Pipeline Products by Development Stage 9
InSightec Ltd Pipeline Products Summary by Development Stage 10
InSightec Ltd Ongoing Clinical Trials by Trial Status 11
InSightec Ltd Ongoing Clinical Trials Summary 12
ExAblate - Brain Cancer - Product Status 13
ExAblate - Brain Cancer - Product Description 13
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Blood-brain Barrier Disruption Using Transcranial MRI-guided Focused Ultrasound with Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours with Doxorubicin 14
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 14
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 14
ExAblate - Breast Cancer - Product Status 15
ExAblate - Breast Cancer - Product Description 15
ExAblate - Breast Cancer - A Clinical Study to Evaluate the Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas 16
ExAblate - Liver Cancer - Product Status 17
ExAblate - Liver Cancer - Product Description 17
ExAblate 2100 Prostate System - Product Status 18
ExAblate 2100 Prostate System - Product Description 18
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Low and Intermediate Risk Prostate Lesions 19
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Low-intermediate Risk Prostate Cancer: Feasibility Study 19
ExAblate Neuro - Product Status 20
ExAblate Neuro - Product Description 20
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy 21
ExAblate Neuro - A Pivotal Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System 21
InSightec Ltd, Key Employees 23
InSightec Ltd, Other Locations 24
Glossary 31